The Efficacy and Safety of Nab-paclitaxel in Pretreated Patients With Extensive Disease of Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Phase I/II Study of Ganetespib in Combination With Doxorubicin
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Molecular Signatures of Relapse in Tissue Samples From Patients With Small Cell Lung Cancer Who Are Receiving Cisplatin and Etoposide
- Status
- WITHDRAWN
- Phase
- N/A
BMS-986012 in Relapsed/Refractory SCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Randomized Study of Maintenance Therapy With MGN1703 in Patients With SCLC
- Status
- COMPLETED
- Phase
- PHASE2
Study of Different Doses of Irinotecan and Cisplatin for First-line Extensive-stage Small-cell Lung Cancer Treatment
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Evaluate the Good and Bad Effects of BIBF1120 in Small Cell Lung Cancer Patients Who Have Previously Benefited From First-line Platinum-based Chemotherapy
- Status
- WITHDRAWN
- Phase
- PHASE2
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
- Status
- RECRUITING
- Phase
- N/A
A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations
- Status
- TERMINATED
- Phase
- PHASE2
Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment
- Status
- UNKNOWN
- Phase
- NA
Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease
- Status
- COMPLETED
- Phase
- PHASE2
Study of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Value of Physical Capacity Tests in Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
Exercise in Advanced Stage Lung Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Clinical Study of Liposomal Doxorubicin Combined With Ifosfamide Second-line Treatment in Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer/ Extensive-disease Small Cell Lung Cancer (MK-3475-011/KEYNOTE-011)
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1